Accelerated Pharma (Accelerated Pharma) Total Stockholders Equity : $-6.99 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Total Stockholders Equity?

Accelerated Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2017 was $-6.99 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Accelerated Pharma's Book Value per Share for the quarter that ended in Mar. 2017 was $-1.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Accelerated Pharma's Debt-to-Equity for the quarter that ended in Mar. 2017 was -0.70.

Accelerated Pharma Total Stockholders Equity Historical Data

The historical data trend for Accelerated Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Total Stockholders Equity Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Total Stockholders Equity

-0.17

-4.43

-6.40

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Total Stockholders Equity	Get a 7-Day Free Trial			-	-4.95	-5.79	-6.40	-6.99

Accelerated Pharma (NAS:ACCP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Accelerated Pharma's Book Value per Share for the quarter that ended in Mar. 2017 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-6.991	-	0)	/	6.89
	=	-1.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Accelerated Pharma's Debt-to-Equity for the quarter that ended in Mar. 2017 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.685	+	1.229)	/	-6.991
	=	-0.70

Accelerated Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines